Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07437924

Bruxism and Pelvic Floor Dysfunction in Young Women

Bruxism and Pelvic Floor Dysfunction in Young Women

Enrolling by Invitation

Interested in participating?

Request Info

Key information

About this study

Bruxism and Pelvic Floor Dysfunction in Young Women: A Cross-Sectional Questionnaire Study Examining the Relationship Between Orofacial Parafunction and Pelvic Floor Symptoms

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female individuals aged 18-30 years
  • Voluntary agreement to participate in the study and approval of the online informed consent form

For the bruxism group:

  • Self-reported teeth clenching and/or grinding behavior during wakefulness or sleep within the past 6 months
  • Presence of clinical findings supporting bruxism (e.g., tooth wear patterns, masseter/temporalis muscle tenderness) identified during a clinical examination conducted at the Faculty of Dentistry

For the non-bruxism group:

  • No self-reported teeth clenching or grinding behavior
  • Absence of clinical findings supporting bruxism upon examination

Bruxism classification will be performed in accordance with the current international consensus, based on self-report combined with clinical findings, within the framework of "probable bruxism" (Verhoeff et al., 2025).

Exclusion criteria

  • Diagnosed temporomandibular joint (TMJ) dysfunction or significant jaw pain syndromes
  • History of major pelvic surgery; early postpartum period (<1 year) or current pregnancy
  • Neurological disorders (e.g., multiple sclerosis, peripheral neuropathies)
  • Presence of active urogenital or colorectal infection/disease
  • Diagnosed pelvic floor pathologies (e.g., advanced pelvic organ prolapse, severe urinary/fecal incontinence)
  • Chronic use of opioids, anticholinergic agents, or muscle relaxants
  • Severe psychiatric disorders (e.g., diagnosed major depressive disorder, generalized anxiety disorder)
  • Receipt of any bruxism-related treatment within the past 6 months (e.g., occlusal splint therapy, botulinum toxin injections, intensive physiotherapy)

Treatment and study plan

Questionnaire and Physical Exam

Diagnostic Test

20 mins questionnaire survey

Primary outcomes

  1. Bruxism Assessment Section

    Time frame: 6 months

    Sleep and awake bruxism will be evaluated according to the bruxism diagnostic criteria established by the American Academy of Sleep Medicine (AASM) in 2023. Bruxism-related pain will be subjectively assessed using the Visual Analog Scale (VAS). The Visual Analogue Scale (VAS) is a 10-cm used to measure pain intensity, where 0 represents "no pain" and 10 represents the "worst imaginable pain. Patients mark their pain level, which is measured in cm or mm to determine the score.

  2. Jaw Function Assessment Section

    Time frame: 6 months

    Jaw function will be evaluated using the Jaw Functional Limitation Scale-20 (JFLS-20). The Jaw Functional Limitation Scale-20 (JFLS-20) scores range from 0 to 200 (or 0-10 average per item), with higher scores indicating more severe jaw functional limitation. It measures 20 items across three constructs-mastication, vertical mobility, and verbal/emotional expression-using a 0-10 scale, with 0 meaning "no limitation" and 10 meaning "severe limitation

  3. Pelvic Floor Assessment Section

    Time frame: 6 months

    Pelvic floor symptoms will be assessed using the Pelvic Floor Distress Inventory-20 (PFDI-20) and the relevant items of the Pelvic Pain Impact Questionnaire. The Pelvic Floor Distress Inventory-20 (PFDI-20) is a questionnaire measuring the severity of pelvic floor dysfunction, with total scores ranging from 0 to 300 (0 = no distress, 300 = maximum distress). It includes three subscales-POPDI-6, UDI-6, and CRADI-8-each scored from 0 to 100, calculated by multiplying the mean of answered items (0-4) by 25

Secondary outcomes

  1. Anxiety Assessment Section

    Time frame: 6 months

    Anxiety levels will be assessed using the State-Trait Anxiety Inventory (STAI - State Anxiety Scale). The State-Trait Anxiety Inventory (STAI-S) assesses temporary, immediate, or situation-specific anxiety using a 20-item self-report questionnaire with 4-point Likert-type responses. Scores range from 20 to 80, with higher scores indicating higher levels of anxiety. A cutoff of 39-40 is often used for detecting clinically significant symptoms.

Sponsors and collaborators

Lead sponsor

Akdeniz University

Other

Collaborators

  • Bilecik Seyh Edebali Universitesi
  • Konya Necmettin Erbakan Üniversitesi

Registry information

Official study title

Bruxism and Pelvic Floor Dysfunction in Young Women: A Cross-Sectional Questionnaire Study Examining the Relationship Between Orofacial Parafunction and Pelvic Floor Symptoms

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 27, 2026
Registry last updated
Mar 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.